Major Events - Minglue Technology (02718) plans to offer 7.219 million Class A shares globally from October 23 to October 28, with cornerstone subscriptions amounting to $59 million [1] - Wisco Properties (00230) received a privatization offer from Wisco Hong Kong at a premium of approximately 104.08%, with trading resuming on October 24 [1] - Junyu Foundation (01757) was acquired by China Venture Capital Holdings for 75% of its shares at a discount of about 79.06%, with trading resuming on October 24 [1] - Kangda Foods (00834) was acquired by Gaosi Shi for approximately 54.69% of the company’s shares at a premium of about 16.23%, with trading resuming on October 24 [1] - Hutchison China MediTech (00013) presented data on HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targeted and Cancer Therapeutics [1] - Giant Bio (02367) received a medical device registration certificate for its Type I α1 collagen lyophilized fiber product [1] - Yiming Anke-B (01541) completed the first patient dosing in the Phase IB/II clinical trial of IMM2510 combined with IMM01 [1] - Heng Rui Medicine (01276) received approval to conduct clinical trials for injection of Rikan Trastuzumab [1] - Hansoh Pharmaceutical (03692) had its application for HS-10365 capsule marketing approval accepted by the National Medical Products Administration [1] - Baixin An-B (02185) completed market access and the first commercial surgery for the IBERIS® RDN system in Switzerland [1] - Haotian International Construction Investment (01341) purchased a total of 646 units of Ethereum as of October 23 [1] Share Buybacks/Reductions - Cornerstone Pharmaceuticals-B (02616) saw CEO Yang Jianxin and senior management purchase an additional 1 million shares [2] - Midea Group (00300) repurchased 1.3434 million A shares for approximately 99.998 million yuan on October 23 [2] - China Communications Construction (01800) repurchased 119.45 million A shares for approximately 10.5994 million yuan on October 23 [2] - Mengniu Dairy (02319) repurchased 700,000 shares for approximately 10.0692 million HKD on October 23 [2] - Lianlian Digital (02598) spent about 7.5555 million HKD to repurchase 967,000 shares on October 23 [2] - Lianyi Rong Technology-W (09959) repurchased 2.47 million shares for approximately 7.4137 million HKD on October 23 [2] - Heng Rui Medicine (01276) repurchased 97,500 A shares for approximately 6.2808 million yuan on October 23 [2] - Gushengtang (02273) repurchased 19,860 shares for approximately 5.8634 million HKD on October 23 [2] Operating Performance - Ping An Good Doctor (01833) reported total revenue of approximately 3.725 billion yuan for the first three quarters, a year-on-year increase of 13.6%, and plans to continue expanding AI technology to enhance medical service efficiency and quality [2] - Sands China Ltd. (01928) reported a 7.5% year-on-year increase in net revenue to $1.9 billion for the third quarter [2] - Livzon Pharmaceutical (01513) announced a net profit attributable to shareholders of 1.754 billion yuan for the first three quarters, a year-on-year increase of 4.86% [2] - China Railway Construction (01186) signed new contracts totaling 1.518765 trillion yuan in the first three quarters, a year-on-year increase of 3.08% [2] - Prada (01913) reported net revenue of 4.07 billion euros for the first three quarters, a year-on-year increase of 9% [2] Additional Performance Metrics - Baio Family Interactive (02100) reported 10.2 million active accounts in the third quarter, a year-on-year increase of 37.8% [3] - Anton Oilfield Services (03337) secured new orders worth 1.273 billion yuan in the third quarter [3]

Core Insights - Ping An Good Doctor reported a revenue of 3.725 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 13.6% [1] - The company achieved a net profit of 184 million yuan, marking a significant year-on-year increase of 72.6% [1] - Adjusted net profit reached 216 million yuan, reflecting a year-on-year growth of 45.7% [1] Financial Performance - Revenue for the first three quarters of 2025 was 3.725 billion yuan, up 13.6% compared to the previous year [1] - Net profit for the same period was 184 million yuan, showing a 72.6% increase year-on-year [1] - Adjusted net profit was 216 million yuan, with a year-on-year growth of 45.7% [1] Business Segments - The F-end (comprehensive financial client) and B-end (enterprise) health management business revenue grew by 21.5% year-on-year [1] - The number of enterprise clients served exceeded 4,500, with B-end paying users increasing by 30.6% compared to the same period last year [1] Future Outlook - The company plans to strengthen collaboration with Ping An Group and promote the digitalization and AI integration of core services [1] - There is an emphasis on enhancing user experience and satisfaction through a more integrated service approach [1]

Core Insights - Ping An Good Doctor reported a revenue of 3.725 billion RMB for the first nine months of 2025, representing a 13.6% increase from 3.279 billion RMB in the same period last year [2][3] - The net profit for the same period was 184 million RMB, a significant increase of 72.6% compared to 107 million RMB in the previous year [3] - Adjusted net profit reached 216 million RMB, up 45.7% from 148 million RMB year-on-year [3] Financial Performance - Revenue for the first nine months of 2025: 3,724,608 thousand RMB, up from 3,278,945 thousand RMB in 2024 [3] - Net profit for the first nine months of 2025: 183,841 thousand RMB, compared to 106,527 thousand RMB in 2024 [3] - Adjusted net profit for the first nine months of 2025: 216,135 thousand RMB, compared to 148,295 thousand RMB in 2024 [3] Strategic Initiatives - The company aims to enhance collaboration with Ping An Group and promote the digitalization and AI integration of core services to improve user satisfaction and reputation [2][3] - The focus is on transforming health insurance service consumption through a more integrated experience [2] Leadership Changes - In October 2025, the company announced the resignation of CEO Li Dou, with Guo Xiaotao appointed as the new chairman and He Mingke as the new CEO [2] Market Position - As of the latest closing, Ping An Good Doctor's stock price was 15.48 HKD, with a market capitalization of 33.459 billion HKD [4]

Core Insights - The company reported a total revenue of 3.725 billion, representing a year-on-year growth of 13.6% for the first three quarters [1] - Adjusted net profit reached 216 million, showing a significant increase of 45.7% compared to the same period last year [1] - The F-end and B-end enterprise health business revenue grew by 21.5%, with over 4,500 corporate clients served during the reporting period [1] Financial Performance - Total revenue for the first three quarters was 3.725 billion, up 13.6% year-on-year [1] - Adjusted net profit was 216 million, reflecting a 45.7% increase from the previous year [1] - The enterprise health business (F-end and B-end) saw a revenue increase of 21.5% [1] Customer Engagement - As of June, nearly 63% of the 247 million individual customers of the parent company enjoy services from the medical and elderly care ecosystem [1] - Customers with access to the ecosystem have 1.5 times more contracts and 4.1 times more assets under management (AUM) compared to those without [1] - By the first half of 2025, nearly 70% of the new business value of the life insurance segment will come from customers enjoying the ecosystem services [1] Home Care Services - The company focused on enhancing services such as medical care, health management, emergency rescue, and remote care during the reporting period [1] - Two group standards for smart elderly care platforms were developed in collaboration with industry, academia, and research [1] - The number of users benefiting from home care services increased by 41% compared to the end of 2024 [1] B-end Business Growth - The number of B-end paying users grew by 30.6% year-on-year, maintaining a strong growth trend [1] - The company served over 4,500 corporate clients in the first three quarters [1] - The number of family doctor membership rights covered over 40 million users by the end of the reporting period [1] AI Integration - The company has strengthened the application depth of medical AI, enhancing the quality and efficiency of professional medical services [2] - A "7+N+1" medical AI product system was launched, achieving a closed loop of "data + model + scenario" [2] - The accuracy of complex disease MDT treatment plans improved to nearly 90%, with average service costs for family doctors decreasing by 52% year-on-year [2]

董事會指本公司的董事會； 首席執行官指董事會不時委任的負責公司管理的本公司高級管理人員； 公 司 指平安健康醫療科技有限公司 ( P I N G A N H E A L T H C A R E A N D TECHNOLOGY COMPANY LIMITED)； PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED 平安健康醫療科技有限公司 董事會可持續發展委員會工作細則 定義 在本工作細則內： 可持續發展委員會指按董事會決議根據本工作細則設立的可持續發展委員會； 公司秘書指本公司公司秘書； 董事指董事會的成員； 集團指公司、其附屬公司及其運營實體； 運營實體指本公司根據合約安排在中國境內控制的運營實體； 上市規則指《香港聯合交易所有限公司證券上市規則》（經不時修訂）； 高級管理人員指本公司首席執行官、總經理、副總經理、財務負責人，以及經董 事會不時確定為本公司高級管理人員的本集團的任何有關其他職員； 管理層指本集團內履行行政管理職責的任何人； 股東指本公司不時的股東；及 聯交所指香港聯合交易所有限公司。 1 第一章 總則 第一條 為完善公司治理，全面、積極履行公 ...

Core Insights - Ping An Good Doctor reported a total revenue of 3.725 billion yuan for the first three quarters, representing a year-on-year growth of 13.6% [1] - The adjusted net profit reached 216 million yuan, an increase of 45.7% compared to the same period last year [1] - The company has served over 4,500 corporate clients, with revenue from F-end and B-end enterprise health management business growing by 21.5% [1][2] Financial Performance - Total revenue for the first three quarters was 3.725 billion yuan, up 13.6% year-on-year [1] - Adjusted net profit was 216 million yuan, reflecting a 45.7% increase from the previous year [1] - B-end paid user count grew by 30.6% year-on-year [2] Business Strategy - The company is advancing the "insurance-medical collaboration" model and enhancing the "insurance + elderly care membership" service system [1] - Collaboration with financial payment partners has been strengthened to improve product and service competitiveness [1] - The customer base enjoying the medical-elderly care ecosystem services is significantly larger, with average contract numbers and average assets under management (AUM) being 1.5 times and 4.1 times higher, respectively, than those not enjoying these services [1] Elderly Care Services - In the third quarter, the company focused on refining services such as medical care, health management, emergency rescue, and remote care [1] - Two group standards for smart elderly care platforms were developed in collaboration with industry, academia, and research institutions [1] - The number of users benefiting from home elderly care services increased by 41% compared to the end of 2024 [1] AI Integration - The company has launched a "7+N+1" medical AI product system to enhance the quality and efficiency of professional medical services [2] - The accuracy of complex disease MDT (multidisciplinary team) treatment plans has improved to nearly 90% [2] - The average service cost per family doctor has decreased by 52% year-on-year due to AI integration [2]

Core Insights - Ping An Good Doctor reported total revenue of 3.725 billion yuan for the first three quarters of this year, representing a year-on-year growth of 13.6% [1] - The net profit reached 184 million yuan, showing a significant increase of 72.6% year-on-year [1] - Adjusted net profit was 216 million yuan, reflecting a year-on-year growth of 45.7% [1] Business Performance - Revenue from both F-end and B-end enterprise health services grew by 21.5% year-on-year [1] - The collaboration in medical insurance on the F-end has deepened, and product capabilities have continuously improved [1] Technological Advancements - Ping An Good Doctor launched a "7+N+1" medical AI product system, achieving a closed loop of "data + model + scenario" [1] - The accuracy of complex disease MDT (multidisciplinary team) treatment plans has improved to nearly 90% [1] - The average service cost per family doctor has decreased by 52% year-on-year [1]

Core Insights - Ping An Good Doctor reported total revenue of 3.725 billion yuan for the first three quarters of the year, representing a year-on-year growth of 13.6% [1] - The company achieved a net profit of 184 million yuan, which is a significant increase of 72.6% year-on-year [1] - Adjusted net profit reached 216 million yuan, reflecting a year-on-year growth of 45.7% [1]

Core Insights - Ping An Good Doctor reported a total revenue of 3.725 billion yuan, a year-on-year increase of 13.6%, and an adjusted net profit of 216 million yuan, up 45.7% compared to the previous year [1] - The company has over 4,500 corporate clients, with a 21.5% year-on-year growth in F-end and B-end enterprise health business revenue [1] - The company is focusing on the "medical insurance collaboration" model, enhancing its "insurance + medical care membership" service system, and has seen a 41% increase in users of home care service rights compared to the end of 2024 [2] Business Development - The company is continuously improving its product system and operational service capabilities in the corporate health management sector, with a 30.6% year-on-year growth in B-end paying users [3] - The company has established a comprehensive service system that integrates online and offline services, supported by AI, to enhance the efficiency of family doctor services [4] - The family doctor membership rights have covered over 40 million users, and the company is actively promoting the national standard for family doctor services [4] AI and Technology Integration - The company has launched a "7+N+1" medical AI product system, achieving a nearly 90% accuracy rate in complex disease MDT treatment plans, and reducing average service costs for family doctors by 52% [5] - The company aims to create a healthy workplace for every enterprise and provide every family with a family doctor, leveraging technology to enhance service quality and efficiency [5]

Core Insights - Ping An Good Doctor (01833) reported a total revenue of RMB 3.725 billion for the first three quarters, representing a year-on-year growth of 13.6% and a net profit of RMB 184 million, up 72.6% from the previous year [1] - The adjusted net profit reached RMB 216 million, reflecting a 45.7% increase compared to the same period last year [1] Group 1: Business Performance - The revenue from F-end and B-end corporate health management business grew by 21.5% year-on-year [1] - The company has served over 4,500 corporate clients by the end of the reporting period, with B-end paying users increasing by 30.6% year-on-year [1] Group 2: Service Model and AI Integration - The company collaborates with Ping An Group to integrate F-end and B-end corporate health traffic, combining online and offline services with comprehensive AI applications [2] - The family doctor service has reached over 40 million users, supported by a certified team and AI capabilities [2] - The home care service model has seen a 41% increase in user rights compared to the end of 2024 [2] Group 3: AI Capability Enhancement - The application of AI technology has significantly improved the quality and efficiency of professional medical services, with the accuracy of complex disease MDT treatment plans rising to nearly 90% [2] - The average service cost for family doctors has decreased by approximately 52% year-on-year due to AI integration [2] - The company plans to continue expanding AI applications across various complex diseases and business scenarios to enhance medical service efficiency and quality [2]